Novo Nordisk

FDA greenlights Wegovy in pill form

FDA approves Novo Nordisk's 25mg oral semaglutide (Wegovy) for weight loss, aiding 16.6% body weight reduction vs. 2.7% placebo.

Next to Trump

Watch: Drug executive collapses in the Oval Office

Novo Nordisk executive Gordon Findlay collapses during a press conference about a new agreement with pharmaceutical companies aimed at reducing prices.

World's Top Insulin Maker to Build Plant in Iran

The world's top insulin maker, Novo Nordisk, announces it would build a $78 million facility in Iran.